Cite
HARVARD Citation
Corbera-Bellalta, M. et al. (2022). Blocking GM-CSF receptor α with mavrilimumab reduces infiltrating cells, pro-inflammatory markers and neoangiogenesis in ex vivo cultured arteries from patients with giant cell arteritis. Annals of the rheumatic diseases. 81 (4), pp. 524-536. [Online].